Search

Your search keyword '"BIANCHI, Andrea"' showing total 77 results

Search Constraints

Start Over You searched for: Author "BIANCHI, Andrea" Remove constraint Author: "BIANCHI, Andrea" Publisher elsevier bv Remove constraint Publisher: elsevier bv
77 results on '"BIANCHI, Andrea"'

Search Results

3. Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells

4. Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer

8. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

9. Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial)

10. An optimized SpCas9 high-fidelity variant for direct protein delivery

11. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines

12. Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features

15. Significant association between FGFR1 mutation frequency and age in central giant cell granuloma

18. Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment

20. An ensemble method for nuclei detection of overlapping cervical cells

21. Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer

22. The m.3890G>A/MT-ND1 mtDNA rare pathogenic variant: Expanding clinical and MRI phenotypes

25. RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients

28. Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities

29. Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer

31. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study

33. Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial

34. Saliency-driven system models for cell analysis with deep learning

35. A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

37. Liquid biopsy for rectal cancer: A systematic review

40. Deep learning for cell image segmentation and ranking

41. Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies

42. Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients

44. Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer

46. First-Line Panitumumab Plus FOLFOX-4 Followed by Maintenance Therapy with Single-Agent Panitumumab or Panitumumab Plus 5-FU/LV in Patients with RAS Wild-Type Metastatic Colorectal Cancer: The Valentino Study

47. Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

48. Alexithymic trait is associated with right IFG and pre-SMA activation in non-emotional response inhibition in healthy subjects

49. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis

Catalog

Books, media, physical & digital resources